Skip to content

Introducing diabetes checks in dental settings: a study to explore whether dental settings can be used to identify new cases of prediabetes and diabetes

INtroducing DIabetes Checks in A denTal sEtting–2

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16227718
Enrollment
10000
Registered
2025-05-19
Start date
2024-12-16
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Nutritional, Metabolic, Endocrine

Interventions

Eligible patients will be identified by the dental practice teams, who will invite those eligible to read the patient information sheet (PIS) about the study and ask any questions they may have. Where

Sponsors

University of Birmingham
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. To read and understand the PIS and consent form sufficiently well to provide informed consent and to participate in the study 2. To be competent to provide informed consent 3. Patients aged >=40 and <=80 years 4. Have not had a diabetes check in the past 12 months

Exclusion criteria

Exclusion criteria: Current key exclusion criteria as of 01/06/2026: 1. Patients aged =80 years 2. Diagnosis of type 1 or type 2 diabetes or NDH (pre-diabetes) 3. Diagnosis of sickle cell or sickle cell trait 4. Unable to provide informed consent 5. Pregnant 6. They have knowingly been tested for diabetes in the past 12 months _____ Previous key exclusion criteria: 1. Patients aged =80 years 2. Diagnosis of type 1 or type 2 diabetes 3. Diagnosis of sickle cell or sickle cell trait 4. Unable to provide informed consent 5. Pregnant 6. They have knowingly been tested for diabetes in the past 12 months

Design outcomes

Primary

MeasureTime frame
Prediabetes/non-diabetic hyperglycaemia (NDH)/diabetes risk is measured using a validated risk assessment questionnaire (LRA/DDS) and Siemens DCA VANTAGE HbA1c point of care test at baseline. Then followed up with referral to GP for definitive testing up to 6 months from baseline.

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, Northern Ireland, Scotland, United Kingdom, Wales

Contacts

Public ContactZehra Yonel
z.yonel@bham.ac.uk+44 (0)1214665128

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 21, 2026